Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Total Valuation
Teva has a market cap or net worth of ₪114.18B. The enterprise value is 51.59B.
Market Cap₪114.18B
Enterprise Value51.59B
Share Statistics
Teva has 1,146,838,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,146,838,700
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Teva’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -1.07%.
Return on Equity (ROE)-0.31
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-1.07%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee447.14K
Profits Per Employee-52.95K
Employee Count37,000
Asset Turnover0.42
Inventory Turnover2.82
Valuation Ratios
The current PE Ratio of Teva is 23.9. Teva’s PEG ratio is -0.08.
PE Ratio23.9
PS Ratio1.53
PB Ratio4.70
Price to Fair Value4.70
Price to FCF33.70
Price to Operating Cash Flow34.36
PEG Ratio-0.08
Income Statement
In the last 12 months, Teva had revenue of 16.54B and earned -1.64B in profits. Earnings per share was -1.45.
Revenue16.54B
Gross Profit8.06B
Operating Income-303.00M
Pretax Income-1.28B
Net Income-1.64B
EBITDA777.00M
Earnings Per Share (EPS)-1.45
Cash Flow
In the last 12 months, operating cash flow was 1.07B and capital expenditures -488.00M, giving a free cash flow of 578.00M billion.
Operating Cash Flow1.07B
Free Cash Flow578.00M
Free Cash Flow per Share0.50
Dividends & Yields
Teva pays an annual dividend of 8.5, resulting in a dividend yield of ―
Dividend Per Share8.5
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change45.78%
50-Day Moving Average9.56K
200-Day Moving Average6.96K
Relative Strength Index (RSI)50.13
Average Volume (3m)1.92M
Important Dates
Teva upcoming earnings date is May 13, 2026, Before Open (Confirmed).
Last Earnings DateJan 28, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Teva as a current ratio of 0.98, with Debt / Equity ratio of 235.74%
Current Ratio0.98
Quick Ratio0.75
Debt to Market Cap0.70
Net Debt to EBITDA19.02
Interest Coverage Ratio-0.30
Taxes
In the past 12 months, Teva has paid 676.00M in taxes.
Income Tax676.00M
Effective Tax Rate-0.53
Enterprise Valuation
Teva EV to EBITDA ratio is 51.51, with an EV/FCF ratio of 53.43.
EV to Sales2.42
EV to EBITDA51.51
EV to Free Cash Flow53.43
EV to Operating Cash Flow32.09
Balance Sheet
Teva has ₪2.20B in cash and marketable securities with ₪17.09B in debt, giving a net cash position of -₪14.89B billion.
Cash & Marketable Securities₪2.20B
Total Debt₪17.09B
Net Cash-₪14.89B
Net Cash Per Share-₪12.98
Tangible Book Value Per Share-₪12.24
Margins
Gross margin is 50.09%, with operating margin of -1.83%, and net profit margin of -9.91%.
Gross Margin50.09%
Operating Margin-1.83%
Pretax Margin-7.76%
Net Profit Margin-9.91%
EBITDA Margin4.70%
EBIT Margin-1.70%
Analyst Forecast
The average price target for Teva is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.10%
EPS Growth Forecast―